Dienogest May Reduce Estradiol- and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture- and Mouse Model-Based Study

Dienogest (DNG) is a therapeutic medication used in endometriosis treatment. Limited data are available regarding its mechanism of action on endometrial cells. Using in vivo and in vitro models, we investigated whether DNG treatment causes significant biological changes in human endometrial stromal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun Jin, Kim, Sung Hoon, Oh, Young Sang, Lee, Sa Ra, Chae, Hee Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687141/
https://www.ncbi.nlm.nih.gov/pubmed/36428561
http://dx.doi.org/10.3390/biomedicines10112992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687141/
https://www.ncbi.nlm.nih.gov/pubmed/36428561
http://dx.doi.org/10.3390/biomedicines10112992

Ejemplares similares